Hence, we next examined the impact of combined treatment on the expression of both immunosuppressive (e.g. PD-L1, PD-L2) and immunostimulatory (e.g. ICOS-L, CD137-L) cell surface proteins in HNSCC cells. The gene discussed is TNFSF9; the disease is head and neck squamous cell carcinoma.